Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASCO 2020 | Myelopreservation and reduced use of supportive care with trilaciclib in patients with SCLC

Jared Weiss, MD, of UNC Lineberger, Chapel Hill, NC, outlines studies investigating trilaciclib, a CDK4/6 inhibitor, for myelopreservation and reduced use of supportive care in small cell lung cancer. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).